BiomX Inc. 8-K

What Happened
BiomX Inc. (through its wholly owned subsidiary Adaptive Phage Therapeutics, LLC, “APT”) filed an 8-K disclosing that APT entered into a Seventh Amendment to its lease with ARE-708 Quince Orchard, LLC dated December 31, 2025. The amendment terminates the lease effective December 31, 2025 and settles related claims. Under the agreement APT will make a one-time payment of $800,000 and the landlord confirmed a draw on an existing letter of credit for $153,557.68. Upon satisfaction of conditions in the amendment, the landlord agreed to release APT and BiomX from further obligations under the lease, subject to certain limited surviving obligations.

Key Details

• Lease termination effective: December 31, 2025.
• One-time cash payment agreed: $800,000.
• Letter of credit draw confirmed by landlord: $153,557.68.
• Seventh Amendment dated December 31, 2025; landlord to release APT and BiomX from further lease obligations after conditions are met.

Why It Matters
This filing documents a legal and financial settlement that removes an ongoing lease obligation for BiomX’s subsidiary, replacing future lease commitments with a one-time cash settlement plus confirmation of an existing letter-of-credit draw. For investors, the transaction creates a known near-term cash outflow (the $800,000 payment and the confirmed ~$153.6K draw) and reduces the company’s future exposure under that lease, subject to any limited surviving obligations. The Seventh Amendment is included as an exhibit to the 8-K.